Brain cancer patients provided new hope with altering drug dosage

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
3,077
Loading...
Alert icon
Sign in or sign up now!
Alert icon
There is no Interactive Transcript.

Uploaded by on Aug 10, 2010

http://sunnybrook.ca/media/item.asp?c=1&i=508 "The RESCUE study demonstrated that more continuous treatment with the drug Temodal (TMZ) is a valuable therapeutic option for patients with recurrent glioblastoma multiforme (GBM)," says Dr. James Perry, Head of the Division of Neurology at Sunnybrook. "The trial results showed an increase in both six-month and one-year progression-free survival of patients undergoing chemotherapy, with excellent tolerability of the dosage, and minimal side effects."

Category:

News & Politics

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • very inspiring, patients can breath now for this very inspiring message

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more